Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drug reviews 2005-12, Vol.11 (4), p.408-418
1. Verfasser:	Scriabine, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	ALS Alzheimer's disease Anticonvulsants Antidepressants Cannabinoids Drug addiction Huntington's disease, Neuroprotective drugs Parkinson's disease
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	418
container_issue	4
container_start_page	408
container_title	CNS drug reviews
container_volume	11
creator	Scriabine, Alexander
description
doi_str_mv	10.1111/j.1527-3458.2005.tb00057.x
format	Article
fullrecord	<record><control><sourceid>wiley_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6741712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNS408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2838-10ae7a24c9c6b41cbe69f51612a03a36946625250825b551b4f8a0a6c8f912753</originalsourceid><addsrcrecordid>eNqVUMtOwzAQtBBIlMI_WJybYDux43BAqspTKuXQVnCzHGM3qdIYOWlpbv0EJP6wX0KiVkUc2cvsandndwaAS4x83MTV3MeURF4QUu4ThKhfJaiByF8fgc6hddzkiCOPsuDtFJyV5RyhkMWYd4CZpJmr6u3my2SmSmG_KJYyh89aV1kxg9bAsVWZrmporIMjvXS2bOpCafgqy7SZqWzRg7f-wO_B6bgPR3alF4l2EJPt5huzHmz_OgcnRualvthjF0zv7yaDR2_48vA06A89RXjAPYykjiQJVaxYEmKVaBYbihkmEgUyYHHIGKGEIk5oQilOQsMlkkxxE2MS0aALbna8H8tkod-VLionc_HhsoV0tbAyE387RZaKmV0JFoU4wqQhuN4RqEZo6bQ57GIkWsvFXLS-itZX0UoTe8vF-vf6Z5br-h-bYjAah4gHP6LtiY0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005</title><source>Wiley Online Library (Open Access Collection)</source><creator>Scriabine, Alexander</creator><creatorcontrib>Scriabine, Alexander</creatorcontrib><identifier>ISSN: 1080-563X</identifier><identifier>EISSN: 1527-3458</identifier><identifier>DOI: 10.1111/j.1527-3458.2005.tb00057.x</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ALS ; Alzheimer's disease ; Anticonvulsants ; Antidepressants ; Cannabinoids ; Drug addiction ; Huntington's disease, Neuroprotective drugs ; Parkinson's disease</subject><ispartof>CNS drug reviews, 2005-12, Vol.11 (4), p.408-418</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741712/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741712/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,27924,27925,46052,46476,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1527-3458.2005.tb00057.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc></links><search><creatorcontrib>Scriabine, Alexander</creatorcontrib><title>Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005</title><title>CNS drug reviews</title><subject>ALS</subject><subject>Alzheimer's disease</subject><subject>Anticonvulsants</subject><subject>Antidepressants</subject><subject>Cannabinoids</subject><subject>Drug addiction</subject><subject>Huntington's disease, Neuroprotective drugs</subject><subject>Parkinson's disease</subject><issn>1080-563X</issn><issn>1527-3458</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqVUMtOwzAQtBBIlMI_WJybYDux43BAqspTKuXQVnCzHGM3qdIYOWlpbv0EJP6wX0KiVkUc2cvsandndwaAS4x83MTV3MeURF4QUu4ThKhfJaiByF8fgc6hddzkiCOPsuDtFJyV5RyhkMWYd4CZpJmr6u3my2SmSmG_KJYyh89aV1kxg9bAsVWZrmporIMjvXS2bOpCafgqy7SZqWzRg7f-wO_B6bgPR3alF4l2EJPt5huzHmz_OgcnRualvthjF0zv7yaDR2_48vA06A89RXjAPYykjiQJVaxYEmKVaBYbihkmEgUyYHHIGKGEIk5oQilOQsMlkkxxE2MS0aALbna8H8tkod-VLionc_HhsoV0tbAyE387RZaKmV0JFoU4wqQhuN4RqEZo6bQ57GIkWsvFXLS-itZX0UoTe8vF-vf6Z5br-h-bYjAah4gHP6LtiY0</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Scriabine, Alexander</creator><general>Blackwell Publishing Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200512</creationdate><title>Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005</title><author>Scriabine, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2838-10ae7a24c9c6b41cbe69f51612a03a36946625250825b551b4f8a0a6c8f912753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>ALS</topic><topic>Alzheimer's disease</topic><topic>Anticonvulsants</topic><topic>Antidepressants</topic><topic>Cannabinoids</topic><topic>Drug addiction</topic><topic>Huntington's disease, Neuroprotective drugs</topic><topic>Parkinson's disease</topic><toplevel>online_resources</toplevel><creatorcontrib>Scriabine, Alexander</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>CNS drug reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Scriabine, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005</atitle><jtitle>CNS drug reviews</jtitle><date>2005-12</date><risdate>2005</risdate><volume>11</volume><issue>4</issue><spage>408</spage><epage>418</epage><pages>408-418</pages><issn>1080-563X</issn><eissn>1527-3458</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/j.1527-3458.2005.tb00057.x</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	ISSN: 1080-563X
ispartof	CNS drug reviews, 2005-12, Vol.11 (4), p.408-418
issn	1080-563X 1527-3458
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6741712
source	Wiley Online Library (Open Access Collection)
subjects	ALS Alzheimer's disease Anticonvulsants Antidepressants Cannabinoids Drug addiction Huntington's disease, Neuroprotective drugs Parkinson's disease
title	Thirty‐fifth Annual Meeting of Society for Neuroscience Washington, D.C., USA November 12–16, 2005
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A33%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thirty%E2%80%90fifth%20Annual%20Meeting%20of%20Society%20for%20Neuroscience%20Washington,%20D.C.,%20USA%20November%2012%E2%80%9316,%202005&rft.jtitle=CNS%20drug%20reviews&rft.au=Scriabine,%20Alexander&rft.date=2005-12&rft.volume=11&rft.issue=4&rft.spage=408&rft.epage=418&rft.pages=408-418&rft.issn=1080-563X&rft.eissn=1527-3458&rft_id=info:doi/10.1111/j.1527-3458.2005.tb00057.x&rft_dat=%3Cwiley_24P%3ECNS408%3C/wiley_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true